Home » Stocks » CohBar

CohBar, Inc. (CWBR)

Stock Price: $0.985 USD 0.007 (0.69%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 57.12M
Revenue (ttm) n/a
Net Income (ttm) -15.39M
Shares Out 57.96M
EPS (ttm) -0.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $0.985
Previous Close $0.979
Change ($) 0.007
Change (%) 0.69%
Day's Open 0.970
Day's Range 0.952 - 0.990
Day's Volume 525,198
52-Week Range 0.850 - 4.250

More Stats

Market Cap 57.12M
Enterprise Value 48.31M
Earnings Date (est) Nov 16, 2020
Ex-Dividend Date n/a
Shares Outstanding 57.96M
Float 43.66M
EPS (basic) -0.35
EPS (diluted) -0.36
FCF / Share -0.22
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 562,947
Short Ratio 0.72
Short % of Float 1.29%
Beta 2.39
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 7.35
Revenue n/a
Operating Income -13.01M
Net Income -15.39M
Free Cash Flow -9.36M
Net Cash 8.81M
Net Cash / Share 0.15
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -51.56%
ROE -143.27%
ROIC -299.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 1
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(534.26% upside)
Current: $0.985
Target: 6.25
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-12.58-15.33-9.86-6.08-3.87-1.81-0.87
Net Income-13.04-15.71-9.83-6.07-3.88-1.82-0.87
Shares Outstanding42.8241.2537.4833.1332.0412.9212.92
Earnings Per Share-0.30-0.38-0.26-0.18-0.12-0.14-0.07
Operating Cash Flow-10.11-10.13-7.63-5.20-3.63-0.84-0.71
Capital Expenditures-0.15-0.42--0.09-0.23--
Free Cash Flow-10.26-10.55-7.64-5.29-3.86-0.84-0.71
Cash & Equivalents12.5622.188.458.6910.291.200.27
Total Debt3.362.92-
Net Cash / Debt9.2119.278.458.4810.090.990.07
Book Value8.1417.967.628.709.811.07-0.03
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name CohBar, Inc.
Country United States
Employees 12
CEO Steven B. Engle

Stock Information

Ticker Symbol CWBR
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CWBR


CohBar, a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) for the treatment of diseases associated with aging and metabolic dysfunction. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, type 2 diabetes mellitus, cancer, atherosclerosis, cardiovascular disease, and neurodegenerative disease, such as Alzheimer's disease. Its lead MBT candidate is CB4211, a novel optimized analog of the MOTS-c mitochondrial-derived peptide for the treatment of NASH and obesity. The company was founded in 2007 and is headquartered in Menlo Park, California.